EUVIMEDEUVIMED entdecken
Crossref

Potential utility of the new ISTH overt disseminated intravascular coagulation scoring system for mortality risk assessment of patients with sepsis, hematopoietic neoplasms, and solid cancers: a nation-wide database study in Japan

Akane Shinkai, Takashi Ito, Ema Hashiguchi, Michiko Katsuno, Yutaka Umemura, Kazuma Yamakawa, Kohji Okamoto, LOCOMOCO Study Group

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Akane Shinkai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Neoplasms, Sepsis, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Disseminated intravascular coagulation (DIC) is characterized by systemic activation of coagulation pathways within the microvasculature, ultimately resulting in multiorgan dysfunction. The International Society on Thrombosis and Haemostasis (ISTH) subcommittee has recently introduced the 2025 overt DIC scoring system for clinical diagnosis. OBJECTIVES: This study aimed to evaluate the clinical relevance of the 2025 ISTH overt DIC scoring system and its proposed cutoff values for the mortality risk assessment in patients with diverse underlying diseases. METHODS: Patient data were extracted from the Japan Medical Data Center database, focusing on individuals diagnosed with sepsis, hematopoietic neoplasms, or solid cancers. Patients were included only if baseline levels of fibrinogen, platelets, prothrombin time (PT), and fibrin-related markers were available on the day of admission. Restricted cubic spline models were applied to evaluate nonlinear associations between coagulation parameters and in-hospital death. RESULTS: Data from 8181 patients with sepsis, 7548 patients with hematopoietic neoplasms, and 11 614 with solid cancers revealed a marked increase in mortality associated with fibrinogen 14 seconds, and D-dimer > 3 mg/L. Among these, PT prolongation and elevated D-dimer demonstrated the strongest associations with mortality. Across all 3 disease groups, in-hospital mortality showed a consistent positive correlation with the ISTH DIC sum score. CONCLUSION: These findings support the prognostic utility of the 2025 ISTH overt DIC scoring system and its proposed cutoff values in evaluating mortality risk among patients with sepsis, hematopoietic malignancies, and solid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disseminated Intravascular CoagulationNeoplasmsSepsisHematologic NeoplasmsBlood CoagulationHumansJapanRisk AssessmentMaleDatabases, FactualFemaleAgedMiddle AgedRisk FactorsHospital MortalityPredictive Value of TestsPrognosisAged, 80 and overBiomarkersFibrin Fibrinogen Degradation ProductsProthrombin TimeAdultFibrinogen

Stichwörter der Autor:innen

cancerdisseminated intravascular coagulation (DIC)hematopoietic neoplasmsepsis

Substanzen

Biomarkersfibrin fragment DFibrin Fibrinogen Degradation ProductsFibrinogen

Autor:innen und Institutionen

  • Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
  • Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan; School of Health Sciences, Kumamoto University, Kumamoto, Japan; Department of Hematology and Immunology, Faculty of Life Science, Kumamoto Unive…
  • School of Health Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Department of Surgery, Kitakyushu City Yahata Hospital, Fukuoka, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Shinkai, A., Ito, T., Hashiguchi, E., Katsuno, M., Umemura, Y., Yamakawa, K., Okamoto, K., & LOCOMOCO Study Group (2026). Potential utility of the new ISTH overt disseminated intravascular coagulation scoring system for mortality risk assessment of patients with sepsis, hematopoietic neoplasms, and solid cancers: a nation-wide database study in Japan. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.10.006

Vancouver

Shinkai A, Ito T, Hashiguchi E, Katsuno M, Umemura Y, Yamakawa K, et al. Potential utility of the new ISTH overt disseminated intravascular coagulation scoring system for mortality risk assessment of patients with sepsis, hematopoietic neoplasms, and solid cancers: a nation-wide database study in Japan. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.10.006

BibTeX
@article{Shinkai2026,
  author = {Shinkai, Akane and Ito, Takashi and Hashiguchi, Ema and Katsuno, Michiko and Umemura, Yutaka and Yamakawa, Kazuma and Okamoto, Kohji and LOCOMOCO Study Group, LOCOMOCO Study Group},
  title = {Potential utility of the new ISTH overt disseminated intravascular coagulation scoring system for mortality risk assessment of patients with sepsis, hematopoietic neoplasms, and solid cancers: a nation-wide database study in Japan},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.10.006}
}
Kostenlos starten →